Versant Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9K Buy
1,380
+1,135
+463% +$21.8K ﹤0.01% 1654
2026
Q1
$4.32K Hold
245
﹤0.01% 2422
2025
Q4
$4.84K Hold
245
﹤0.01% 2264
2025
Q3
$4.28K Sell
245
-7
-3% -$104 ﹤0.01% 2266
2025
Q2
$3.53K Buy
252
+79
+46% +$1.27K ﹤0.01% 2270
2025
Q1
$3.22K Buy
+173
New +$2.58K ﹤0.01% 2183
2023
Q3
Sell
-102
Closed -$587 1939
2023
Q2
$587 Buy
+102
New +$660 ﹤0.01% 1785

Other funds holding ALHC

Versant Capital Management's ALHC Position: Q2 2026 in Review

Versant Capital Management increased its Alignment Healthcare (ALHC) stake by 463% in Q2 2026, buying an estimated $21.8K and bringing the position to 1,380 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Versant Capital Management first reported a position in ALHC in Q2 2023 and has held it in 7 quarters since. 18 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Versant Capital Management held 1,380 shares of Alignment Healthcare worth $32.9K as of Q2 2026.
  • Versant Capital Management bought 1,135 Alignment Healthcare shares in Q2 2026, an estimated $21.8K.
  • Alignment Healthcare made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1654 holding.
  • Versant Capital Management first reported a position in Alignment Healthcare in Q2 2023 and has held it in 7 quarters since.
  • 18 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.